IBDEI00X ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1683,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,1683,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,1684,0)
 ;;=F19.97^^18^138^35
 ;;^UTILITY(U,$J,358.3,1684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1684,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
 ;;^UTILITY(U,$J,358.3,1684,1,4,0)
 ;;=4^F19.97
 ;;^UTILITY(U,$J,358.3,1684,2)
 ;;=^5003465
 ;;^UTILITY(U,$J,358.3,1685,0)
 ;;=F01.51^^18^138^37
 ;;^UTILITY(U,$J,358.3,1685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1685,1,3,0)
 ;;=3^Vascular Dementia w/ Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,1685,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,1685,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,1686,0)
 ;;=G10.^^18^138^24
 ;;^UTILITY(U,$J,358.3,1686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1686,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,1686,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,1686,2)
 ;;=^5003751^F02.81
 ;;^UTILITY(U,$J,358.3,1687,0)
 ;;=G10.^^18^138^25
 ;;^UTILITY(U,$J,358.3,1687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1687,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,1687,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,1687,2)
 ;;=^5003751^F02.80
 ;;^UTILITY(U,$J,358.3,1688,0)
 ;;=G90.3^^18^138^27
 ;;^UTILITY(U,$J,358.3,1688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1688,1,3,0)
 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,1688,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,1688,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,1689,0)
 ;;=G91.2^^18^138^28
 ;;^UTILITY(U,$J,358.3,1689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1689,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,1689,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,1689,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,1690,0)
 ;;=G91.2^^18^138^29
 ;;^UTILITY(U,$J,358.3,1690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1690,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,1690,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,1690,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,1691,0)
 ;;=G30.8^^18^138^2
 ;;^UTILITY(U,$J,358.3,1691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1691,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,1691,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,1691,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,1692,0)
 ;;=G31.09^^18^138^19
 ;;^UTILITY(U,$J,358.3,1692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1692,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,1692,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,1692,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,1693,0)
 ;;=G20.^^18^138^30
 ;;^UTILITY(U,$J,358.3,1693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1693,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,1693,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,1693,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,1694,0)
 ;;=G20.^^18^138^31
 ;;^UTILITY(U,$J,358.3,1694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1694,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,1694,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,1694,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,1695,0)
 ;;=G23.1^^18^138^34
 ;;^UTILITY(U,$J,358.3,1695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1695,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,1695,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,1695,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,1696,0)
 ;;=E53.8^^18^139^7
 ;;^UTILITY(U,$J,358.3,1696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1696,1,3,0)
 ;;=3^Deficiency of Vitamin B Group,Other Spec
 ;;^UTILITY(U,$J,358.3,1696,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,1696,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,1697,0)
 ;;=F44.4^^18^139^5
 ;;^UTILITY(U,$J,358.3,1697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1697,1,3,0)
 ;;=3^Conversion Disorder w/ Motor Symptom/Deficit
 ;;^UTILITY(U,$J,358.3,1697,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,1697,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,1698,0)
 ;;=F44.6^^18^139^6
 ;;^UTILITY(U,$J,358.3,1698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1698,1,3,0)
 ;;=3^Conversion Disorder w/ Sensory Symptom/Deficit
 ;;^UTILITY(U,$J,358.3,1698,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,1698,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,1699,0)
 ;;=F10.20^^18^139^1
 ;;^UTILITY(U,$J,358.3,1699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1699,1,3,0)
 ;;=3^Alcohol Dependence Uncomplicated
 ;;^UTILITY(U,$J,358.3,1699,1,4,0)
 ;;=4^F10.20
 ;;^UTILITY(U,$J,358.3,1699,2)
 ;;=^5003081
 ;;^UTILITY(U,$J,358.3,1700,0)
 ;;=F32.9^^18^139^15
 ;;^UTILITY(U,$J,358.3,1700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1700,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,1700,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,1700,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,1701,0)
 ;;=G91.1^^18^139^16
 ;;^UTILITY(U,$J,358.3,1701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1701,1,3,0)
 ;;=3^Obstructive Hydrocephalus
 ;;^UTILITY(U,$J,358.3,1701,1,4,0)
 ;;=4^G91.1
 ;;^UTILITY(U,$J,358.3,1701,2)
 ;;=^84947
 ;;^UTILITY(U,$J,358.3,1702,0)
 ;;=I95.1^^18^139^17
 ;;^UTILITY(U,$J,358.3,1702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1702,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,1702,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,1702,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,1703,0)
 ;;=I95.89^^18^139^14
 ;;^UTILITY(U,$J,358.3,1703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1703,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,1703,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,1703,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,1704,0)
 ;;=R55.^^18^139^21
 ;;^UTILITY(U,$J,358.3,1704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1704,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,1704,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,1704,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,1705,0)
 ;;=G47.10^^18^139^12
 ;;^UTILITY(U,$J,358.3,1705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1705,1,3,0)
 ;;=3^Hypersomnia,Unspec
 ;;^UTILITY(U,$J,358.3,1705,1,4,0)
 ;;=4^G47.10
 ;;^UTILITY(U,$J,358.3,1705,2)
 ;;=^332926
 ;;^UTILITY(U,$J,358.3,1706,0)
 ;;=G47.30^^18^139^20
 ;;^UTILITY(U,$J,358.3,1706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1706,1,3,0)
 ;;=3^Sleep Apnea,Unspec
 ;;^UTILITY(U,$J,358.3,1706,1,4,0)
 ;;=4^G47.30
 ;;^UTILITY(U,$J,358.3,1706,2)
 ;;=^5003977
 ;;^UTILITY(U,$J,358.3,1707,0)
 ;;=R20.0^^18^139^2
 ;;^UTILITY(U,$J,358.3,1707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1707,1,3,0)
 ;;=3^Anesthesia of Skin
 ;;^UTILITY(U,$J,358.3,1707,1,4,0)
 ;;=4^R20.0
 ;;^UTILITY(U,$J,358.3,1707,2)
 ;;=^5019278
 ;;^UTILITY(U,$J,358.3,1708,0)
 ;;=F44.7^^18^139^4
 ;;^UTILITY(U,$J,358.3,1708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1708,1,3,0)
 ;;=3^Conversion Disorder w/ Mixed Symptoms
 ;;^UTILITY(U,$J,358.3,1708,1,4,0)
 ;;=4^F44.7
 ;;^UTILITY(U,$J,358.3,1708,2)
 ;;=^5003582
 ;;^UTILITY(U,$J,358.3,1709,0)
 ;;=G91.9^^18^139^11
 ;;^UTILITY(U,$J,358.3,1709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1709,1,3,0)
 ;;=3^Hydrocephalus,Unspec
 ;;^UTILITY(U,$J,358.3,1709,1,4,0)
 ;;=4^G91.9
 ;;^UTILITY(U,$J,358.3,1709,2)
 ;;=^5004178
 ;;^UTILITY(U,$J,358.3,1710,0)
 ;;=G98.8^^18^139^9
 ;;^UTILITY(U,$J,358.3,1710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1710,1,3,0)
 ;;=3^Disorders of Nervous System,Other
 ;;^UTILITY(U,$J,358.3,1710,1,4,0)
 ;;=4^G98.8
 ;;^UTILITY(U,$J,358.3,1710,2)
 ;;=^5004214
 ;;^UTILITY(U,$J,358.3,1711,0)
 ;;=R53.83^^18^139^10
 ;;^UTILITY(U,$J,358.3,1711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1711,1,3,0)
 ;;=3^Fatigue,Other
 ;;^UTILITY(U,$J,358.3,1711,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,1711,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,1712,0)
 ;;=G96.8^^18^139^8
 ;;^UTILITY(U,$J,358.3,1712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1712,1,3,0)
 ;;=3^Disorders of CNS,Other Spec
 ;;^UTILITY(U,$J,358.3,1712,1,4,0)
 ;;=4^G96.8
 ;;^UTILITY(U,$J,358.3,1712,2)
 ;;=^5004199
 ;;^UTILITY(U,$J,358.3,1713,0)
 ;;=T50.901A^^18^139^18
 ;;^UTILITY(U,$J,358.3,1713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1713,1,3,0)
 ;;=3^Poisoning by Drug/Meds/Bio Subst,Accidental,Init
 ;;^UTILITY(U,$J,358.3,1713,1,4,0)
 ;;=4^T50.901A
 ;;^UTILITY(U,$J,358.3,1713,2)
 ;;=^5052148
 ;;^UTILITY(U,$J,358.3,1714,0)
 ;;=G93.3^^18^139^19
 ;;^UTILITY(U,$J,358.3,1714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1714,1,3,0)
 ;;=3^Postviral Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,1714,1,4,0)
 ;;=4^G93.3
 ;;^UTILITY(U,$J,358.3,1714,2)
 ;;=^5004181
 ;;^UTILITY(U,$J,358.3,1715,0)
 ;;=R53.1^^18^139^22
 ;;^UTILITY(U,$J,358.3,1715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1715,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,1715,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,1715,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,1716,0)
 ;;=G93.2^^18^139^3
 ;;^UTILITY(U,$J,358.3,1716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1716,1,3,0)
 ;;=3^Benign Intracranial Hypertension
 ;;^UTILITY(U,$J,358.3,1716,1,4,0)
 ;;=4^G93.2
 ;;^UTILITY(U,$J,358.3,1716,2)
 ;;=^5004180
 ;;^UTILITY(U,$J,358.3,1717,0)
 ;;=I95.0^^18^139^13
 ;;^UTILITY(U,$J,358.3,1717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1717,1,3,0)
 ;;=3^Hypotension,Idiopathic
 ;;^UTILITY(U,$J,358.3,1717,1,4,0)
 ;;=4^I95.0
 ;;^UTILITY(U,$J,358.3,1717,2)
 ;;=^5008076
 ;;^UTILITY(U,$J,358.3,1718,0)
 ;;=I48.0^^18^140^5
 ;;^UTILITY(U,$J,358.3,1718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1718,1,3,0)
 ;;=3^Atrial Fibrillation,Proxysmal
 ;;^UTILITY(U,$J,358.3,1718,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,1718,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,1719,0)
 ;;=R55.^^18^140^6
 ;;^UTILITY(U,$J,358.3,1719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1719,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,1719,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,1719,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,1720,0)
 ;;=I48.11^^18^140^3
 ;;^UTILITY(U,$J,358.3,1720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1720,1,3,0)
 ;;=3^Atrial Fibrillation,Longstanding Persistent
 ;;^UTILITY(U,$J,358.3,1720,1,4,0)
 ;;=4^I48.11
 ;;^UTILITY(U,$J,358.3,1720,2)
 ;;=^5158046
 ;;^UTILITY(U,$J,358.3,1721,0)
 ;;=I48.19^^18^140^1
 ;;^UTILITY(U,$J,358.3,1721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1721,1,3,0)
 ;;=3^Atrial Fibrillation,Chronic Persistent
 ;;^UTILITY(U,$J,358.3,1721,1,4,0)
 ;;=4^I48.19
 ;;^UTILITY(U,$J,358.3,1721,2)
 ;;=^5158047
 ;;^UTILITY(U,$J,358.3,1722,0)
 ;;=I48.20^^18^140^2
 ;;^UTILITY(U,$J,358.3,1722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1722,1,3,0)
 ;;=3^Atrial Fibrillation,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,1722,1,4,0)
 ;;=4^I48.20
 ;;^UTILITY(U,$J,358.3,1722,2)
 ;;=^5158048
 ;;^UTILITY(U,$J,358.3,1723,0)
 ;;=I48.21^^18^140^4
 ;;^UTILITY(U,$J,358.3,1723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1723,1,3,0)
 ;;=3^Atrial Fibrillation,Permanent
 ;;^UTILITY(U,$J,358.3,1723,1,4,0)
 ;;=4^I48.21
 ;;^UTILITY(U,$J,358.3,1723,2)
 ;;=^304710
 ;;^UTILITY(U,$J,358.3,1724,0)
 ;;=G00.9^^18^141^3
 ;;^UTILITY(U,$J,358.3,1724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1724,1,3,0)
 ;;=3^Bacterial Meningitis,Unspec
 ;;^UTILITY(U,$J,358.3,1724,1,4,0)
 ;;=4^G00.9
 ;;^UTILITY(U,$J,358.3,1724,2)
 ;;=^5003724
 ;;^UTILITY(U,$J,358.3,1725,0)
 ;;=G04.00^^18^141^1
 ;;^UTILITY(U,$J,358.3,1725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1725,1,3,0)
 ;;=3^Acute Disseminated Encephalitis/Encephalomyelitis,Unspec
 ;;^UTILITY(U,$J,358.3,1725,1,4,0)
 ;;=4^G04.00
 ;;^UTILITY(U,$J,358.3,1725,2)
 ;;=^5003730
 ;;^UTILITY(U,$J,358.3,1726,0)
 ;;=G04.90^^18^141^5
 ;;^UTILITY(U,$J,358.3,1726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1726,1,3,0)
 ;;=3^Encephalitis/Encephalomyelitis,Unspec
 ;;^UTILITY(U,$J,358.3,1726,1,4,0)
 ;;=4^G04.90
 ;;^UTILITY(U,$J,358.3,1726,2)
 ;;=^5003741
 ;;^UTILITY(U,$J,358.3,1727,0)
 ;;=G35.^^18^141^7
 ;;^UTILITY(U,$J,358.3,1727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1727,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,1727,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,1727,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,1728,0)
 ;;=G36.0^^18^141^8
 ;;^UTILITY(U,$J,358.3,1728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1728,1,3,0)
 ;;=3^Neuromyelitis Optica
 ;;^UTILITY(U,$J,358.3,1728,1,4,0)
 ;;=4^G36.0
 ;;^UTILITY(U,$J,358.3,1728,2)
 ;;=^5003817
 ;;^UTILITY(U,$J,358.3,1729,0)
 ;;=G37.3^^18^141^2
 ;;^UTILITY(U,$J,358.3,1729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1729,1,3,0)
 ;;=3^Acute Transverse Myelitis in Demyelinating Disease of CNSL
 ;;^UTILITY(U,$J,358.3,1729,1,4,0)
 ;;=4^G37.3
 ;;^UTILITY(U,$J,358.3,1729,2)
 ;;=^5003824
 ;;^UTILITY(U,$J,358.3,1730,0)
 ;;=G61.0^^18^141^6
 ;;^UTILITY(U,$J,358.3,1730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1730,1,3,0)
 ;;=3^Guillain-Barre Syndrome
 ;;^UTILITY(U,$J,358.3,1730,1,4,0)
 ;;=4^G61.0
 ;;^UTILITY(U,$J,358.3,1730,2)
 ;;=^53405
 ;;^UTILITY(U,$J,358.3,1731,0)
 ;;=G61.81^^18^141^4
 ;;^UTILITY(U,$J,358.3,1731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1731,1,3,0)
 ;;=3^Chronic Inflammatory Demyelinating Polyneuritis
 ;;^UTILITY(U,$J,358.3,1731,1,4,0)
 ;;=4^G61.81
 ;;^UTILITY(U,$J,358.3,1731,2)
 ;;=^328480
 ;;^UTILITY(U,$J,358.3,1732,0)
 ;;=D86.81^^18^141^9
 ;;^UTILITY(U,$J,358.3,1732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1732,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,1732,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,1732,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,1733,0)
 ;;=G51.0^^18^142^2
 ;;^UTILITY(U,$J,358.3,1733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1733,1,3,0)
 ;;=3^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,1733,1,4,0)
 ;;=4^G51.0
 ;;^UTILITY(U,$J,358.3,1733,2)
 ;;=^13238
 ;;^UTILITY(U,$J,358.3,1734,0)
 ;;=G54.0^^18^142^3
 ;;^UTILITY(U,$J,358.3,1734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1734,1,3,0)
 ;;=3^Brachial Plexus Disorders
 ;;^UTILITY(U,$J,358.3,1734,1,4,0)
 ;;=4^G54.0
 ;;^UTILITY(U,$J,358.3,1734,2)
 ;;=^5004007
 ;;^UTILITY(U,$J,358.3,1735,0)
 ;;=G56.00^^18^142^4
 ;;^UTILITY(U,$J,358.3,1735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1735,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Unspec Upper Limb
 ;;^UTILITY(U,$J,358.3,1735,1,4,0)
 ;;=4^G56.00
 ;;^UTILITY(U,$J,358.3,1735,2)
 ;;=^5004017
 ;;^UTILITY(U,$J,358.3,1736,0)
 ;;=G56.20^^18^142^14
 ;;^UTILITY(U,$J,358.3,1736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1736,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Unspec Upper Limb
 ;;^UTILITY(U,$J,358.3,1736,1,4,0)
 ;;=4^G56.20
 ;;^UTILITY(U,$J,358.3,1736,2)
 ;;=^5004023
 ;;^UTILITY(U,$J,358.3,1737,0)
 ;;=G56.90^^18^142^18
 ;;^UTILITY(U,$J,358.3,1737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1737,1,3,0)
 ;;=3^Mononeuropathy,Unspec Upper Limb
 ;;^UTILITY(U,$J,358.3,1737,1,4,0)
 ;;=4^G56.90
 ;;^UTILITY(U,$J,358.3,1737,2)
 ;;=^5004035
 ;;^UTILITY(U,$J,358.3,1738,0)
 ;;=G57.00^^18^142^13
 ;;^UTILITY(U,$J,358.3,1738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1738,1,3,0)
 ;;=3^Lesion Sciatic Nerve,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,1738,1,4,0)
 ;;=4^G57.00
 ;;^UTILITY(U,$J,358.3,1738,2)
 ;;=^5004038
 ;;^UTILITY(U,$J,358.3,1739,0)
 ;;=G57.10^^18^142^15
 ;;^UTILITY(U,$J,358.3,1739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1739,1,3,0)
 ;;=3^Meralgia Paresthetica,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,1739,1,4,0)
 ;;=4^G57.10
 ;;^UTILITY(U,$J,358.3,1739,2)
 ;;=^5004041
 ;;^UTILITY(U,$J,358.3,1740,0)
 ;;=G57.90^^18^142^17
 ;;^UTILITY(U,$J,358.3,1740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1740,1,3,0)
 ;;=3^Mononeuropathy,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,1740,1,4,0)
 ;;=4^G57.90
 ;;^UTILITY(U,$J,358.3,1740,2)
 ;;=^5004061
 ;;^UTILITY(U,$J,358.3,1741,0)
 ;;=G58.7^^18^142^16
 ;;^UTILITY(U,$J,358.3,1741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1741,1,3,0)
 ;;=3^Mononeuritis Multiplex
 ;;^UTILITY(U,$J,358.3,1741,1,4,0)
 ;;=4^G58.7
 ;;^UTILITY(U,$J,358.3,1741,2)
 ;;=^5004063
 ;;^UTILITY(U,$J,358.3,1742,0)
 ;;=G60.0^^18^142^8
 ;;^UTILITY(U,$J,358.3,1742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1742,1,3,0)
 ;;=3^Hereditary Motor & Sensory Neuropathy
 ;;^UTILITY(U,$J,358.3,1742,1,4,0)
 ;;=4^G60.0
 ;;^UTILITY(U,$J,358.3,1742,2)
 ;;=^5004067
 ;;^UTILITY(U,$J,358.3,1743,0)
 ;;=G60.3^^18^142^9
 ;;^UTILITY(U,$J,358.3,1743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1743,1,3,0)
 ;;=3^Idiopathic Progressive Neuropathy
 ;;^UTILITY(U,$J,358.3,1743,1,4,0)
 ;;=4^G60.3
 ;;^UTILITY(U,$J,358.3,1743,2)
 ;;=^5004069
 ;;^UTILITY(U,$J,358.3,1744,0)
 ;;=G62.0^^18^142^7
 ;;^UTILITY(U,$J,358.3,1744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1744,1,3,0)
 ;;=3^Drug-Induced Polyneuropathy
 ;;^UTILITY(U,$J,358.3,1744,1,4,0)
 ;;=4^G62.0
 ;;^UTILITY(U,$J,358.3,1744,2)
 ;;=^5004075
 ;;^UTILITY(U,$J,358.3,1745,0)
 ;;=G62.1^^18^142^1
 ;;^UTILITY(U,$J,358.3,1745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1745,1,3,0)
 ;;=3^Alcoholic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,1745,1,4,0)
 ;;=4^G62.1
 ;;^UTILITY(U,$J,358.3,1745,2)
 ;;=^5004076
 ;;^UTILITY(U,$J,358.3,1746,0)
 ;;=G63.^^18^142^22
 ;;^UTILITY(U,$J,358.3,1746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1746,1,3,0)
 ;;=3^Polyneuropathy in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,1746,1,4,0)
 ;;=4^G63.
 ;;^UTILITY(U,$J,358.3,1746,2)
 ;;=^5004080
 ;;^UTILITY(U,$J,358.3,1747,0)
 ;;=G70.00^^18^142^20
 ;;^UTILITY(U,$J,358.3,1747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1747,1,3,0)
 ;;=3^Myasthenia Gravis w/o Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,1747,1,4,0)
 ;;=4^G70.00
 ;;^UTILITY(U,$J,358.3,1747,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,1748,0)
 ;;=G70.01^^18^142^19
 ;;^UTILITY(U,$J,358.3,1748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1748,1,3,0)
 ;;=3^Myasthenia Gravis w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,1748,1,4,0)
 ;;=4^G70.01
 ;;^UTILITY(U,$J,358.3,1748,2)
 ;;=^329921
 ;;^UTILITY(U,$J,358.3,1749,0)
 ;;=G70.80^^18^142^12
 ;;^UTILITY(U,$J,358.3,1749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1749,1,3,0)
 ;;=3^Lambert-Eaton Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,1749,1,4,0)
 ;;=4^G70.80
 ;;^UTILITY(U,$J,358.3,1749,2)
 ;;=^340608
 ;;^UTILITY(U,$J,358.3,1750,0)
 ;;=G72.0^^18^142^6
 ;;^UTILITY(U,$J,358.3,1750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1750,1,3,0)
 ;;=3^Drug-Induced Myopathy
 ;;^UTILITY(U,$J,358.3,1750,1,4,0)
 ;;=4^G72.0
 ;;^UTILITY(U,$J,358.3,1750,2)
 ;;=^5004095
 ;;^UTILITY(U,$J,358.3,1751,0)
 ;;=G72.41^^18^142^10
 ;;^UTILITY(U,$J,358.3,1751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1751,1,3,0)
 ;;=3^Inclusion Body Myositis
 ;;^UTILITY(U,$J,358.3,1751,1,4,0)
 ;;=4^G72.41
 ;;^UTILITY(U,$J,358.3,1751,2)
 ;;=^5004098
 ;;^UTILITY(U,$J,358.3,1752,0)
 ;;=G72.49^^18^142^11
 ;;^UTILITY(U,$J,358.3,1752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1752,1,3,0)
 ;;=3^Inflammatory & Immune Myopathies NEC
 ;;^UTILITY(U,$J,358.3,1752,1,4,0)
 ;;=4^G72.49
 ;;^UTILITY(U,$J,358.3,1752,2)
 ;;=^5004099
 ;;^UTILITY(U,$J,358.3,1753,0)
 ;;=E11.40^^18^142^5
 ;;^UTILITY(U,$J,358.3,1753,1,0)
 ;;=^358.31IA^4^2
